GenObeDia Biotechnology was established in January 2020 within Acıbadem University, supported by the TÜBİTAK 1512 Grant Program. The company continues to develop innovative products with ongoing support from TÜBİTAK and KOSGEB.
GenObeDia focuses on research and development (R&D) of innovative and high value-added diagnostic kits, particularly in the healthcare field for obesity and diabetes.